UK markets close in 1 hour 32 minutes

Pfizer Inc. (0Q1N.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
50.83+0.25 (+0.49%)
As of 06:12PM GMT. Market open.
Full screen
Previous close50.58
Open50.82
BidN/A x N/A
AskN/A x N/A
Day's range50.26 - 50.82
52-week range50.26 - 50.82
Volume247,152
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date06 Feb 2023 - 10 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est38.30
  • Business Wire

    Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease

    NEW YORK & CAMBRIDGE, Mass., December 06, 2022--Pfizer Inc. (NYSE: PFE) and Clear Creek Bio, Inc. today announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARS-CoV-2 papain-like protease (PLpro) for the oral treatment of COVID-19. PLpro is an essential enzyme, which, along with the main protease (Mpro), plays an important role in viral replication. This program will expand Pfizer’s innovative anti-infective p

  • Business Wire

    Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day

    NEW YORK, December 01, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term Launches + High-Value Pipeline Day on Monday, December 12, 2022 from 1:00 p.m. EST to 6:00 p.m. EST, with an approximately 30 minute break at the midpoint. Pfizer business executives and scientific leadership will provide updates on the company’s potential near-term product launches and key high-value pipeline programs, both of which are expected to be pri

  • Business Wire

    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

    NEW YORK, November 28, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business; Kevin Sullivan, Global Specialty Care & U.S. President; and Navin Katyal, U.S. Commercial and Global Business Lead for mRNA Portfolio, at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 4:20 p.m. EST.